JDD in the Media

Latest Article Citations

By December 17, 2019No Comments

“Even dermatologists misdiagnose and mismanage fungal infections.”

Dermatologists face a number of obstacles when using fungal diagnostic preparations to diagnose cutaneous fungal infections.

In an article from Dermatology Times, Lisette Hilton cites findings from an August 2019 study (“Use of In-Office Preparations by Dermatologists for the Diagnosis of Cutaneous Fungal Infections“) published in the JDD that although cutaneous fungal infections account for millions of office visits per year, yet their varied presentations often lead to misdiagnosis.

“Cutaneous fungal infections account for 3.5 to 6.5 million office visits per year1 – despite being common, their diverse presentations frequently lead to misdiagnosis.2,3 In one study, only 4 out of 13 dermatophytosis cases presented were accurately identified by more than 75% of board-certified dermatologists.4 In addition, other conditions can mimic fungal infections, such as mycosis fungoides5 or inflammatory diseases including annular psoriasis, secondary syphilis, and pityriasis rosea.4″

Despite the importance of bedside fungal preparations, dermatologists’ attitudes towards and utilization of these tests are unknown. An IRB-approved survey was disseminated to the Orlando Dermatology Aesthetic and Clinical Conference (ODAC) email list and the data was collected via an internet-based platform. The survey study examined dermatologists’ perceptions of fungal preparations and identified barriers preventing their use.

Read Article Now

You May Also Like

Journal of Drugs in Dermatology JDD Article about Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional AnalysisDerm CommunityFeatured ArticlesLatest News
December 23, 2025

Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis

Coverage clears the way: Most large private insurers pay for Botox and friends for axillary hyperhidrosis In one of our January JDD articles, we reviewed public medical‑policy guidance from the…
Journal of Drugs in Dermatology JDD Article about The Overlooked Burden: Psychodermatologic Needs of Hispanic and Latinx Communities in the United StatesDerm CommunityFeatured ArticlesLatest NewsSkin of Color
December 10, 2025

The Overlooked Burden: Psychodermatologic Needs of Hispanic and Latinx Communities in the United States

Review highlights higher psychiatric comorbidity, systemic barriers to care, and the value of integrated psychodermatologic models This article in the December 2025 issue of JDD discusses how Hispanic and Latinx…
Journal of Drugs in Dermatology JDD Author Spotlight featuring Natalia N. Khosla MD.AlopeciaAuthor SpotlightDerm CommunityFeatured ArticlesLatest NewsThe Latest
July 22, 2025

July Author Spotlight

Author Spotlight: Dr. Natalia Neha Khosla on Health Equity, Inflammation, and Innovation in Dermatology July’s JDD Author Spotlight  features Natalia Neha Khosla, MD MSc, author of the July article, “Socioeconomic…